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Serratia marcescens is an opportunistic bacterial pathogen. It is notorious for its 35 
increasing antimicrobial resistance and its potential to cause outbreaks of 36 
colonization and infections predominantly in neonatal intensive care units (NICUs). 37 
There, its spread requires rapid infection control response. In order to understand its 38 
spread, detailed molecular typing is key. We present a whole genome multi-locus 39 
sequence typing (wgMLST) method for S. marcescens. Using a set of 299 publicly 40 
available whole genome sequences (WGS) we developed an initial wgMLST system 41 
consisting of 9377 gene loci. This included 1455 loci occurring in all reference 42 
genomes and 7922 accessory loci. This closed system was validated using three 43 
geographically diverse collections of S. marcescens consisting of 111 clinical 44 
isolates implicated in nosocomial dissemination events in three hospitals. The 45 
validation procedure showed a full match between epidemiological data and the 46 
wgMLST analyses. We set the cut-off value for epidemiological (non-)relatedness at 47 
20 different alleles, although for the majority of outbreak-clustered isolates this 48 
difference was limited to 4 alleles. This shows that the wgMLST system for S. 49 
marcescens provides prospects of successful future monitoring for the 50 













The new Gold Standard in microbial epidemiology is genome sequencing. The use 54 
of whole genome (draft) sequences (WGS) to compare bacterial isolates in detail, 55 
and to delineate their spread, is based on either the detection of single nucleotide 56 
variants or polymorphisms (SNVs and SNPs) or on the assessment of overall gene 57 
content including allelic differences between strains by whole genome multi-locus 58 
sequence typing (wgMLST) (1-4). Both methods have their advantages and 59 
disadvantages. Where SNP analysis may have a higher intrinsic discriminatory 60 
power (since it covers coding and non-coding regions) and better resolves the 61 
ancestral relationship between lineages, wgMLST usually provides a more stable, 62 
generically applicable system, with results that are easier to translate into relevant 63 
epidemiological differences between isolates. wgMLST schemes have been 64 
developed for a multitude of microbial organisms, with the main driver being the 65 
development of a universal “typing language” (5-7). This will facilitate the monitoring 66 
of local, institutional spread of certain pathogens but will also extend into regional, 67 
national, international, and possibly even global monitoring for the dissemination of 68 
given bacterial strain types (8-10). This will aid communication in international public 69 
health management and should in the end lead to early recognition of the 70 
emergence and spread of pathogenic microbial strains. Furthermore, this is of 71 
importance in the current era of multi-drug resistant bacteria and their global 72 
dispersal promoted by human travelling, international patient transfer, nosocomial 73 
transmission, and excessive use of antimicrobials. 74 
Serratia marcescens is a bacterial pathogen for which no wgMLST scheme has been 75 
defined yet. S. marcescens is notorious for its pathogenicity in plants (11) but also in 76 
preterm neonates (12,13). Therefore, setting up a robust epidemiological wgMLST 77 
typing scheme is essential for monitoring and interrupting outbreaks in neonatal 78 
intensive care units (NICU) as well as other medical settings. In addition, S. 79 
marcescens is capable of efficiently acquiring multiple resistance determinants (that 80 
are unreliable epidemiological markers) which adds to its clinical relevance (14-18). 81 
We have developed a proprietary wgMLST toolbox for S. marcescens based on 82 
publicly available WGS data. We have validated the scheme using epidemiologically 83 
related isolates collected during recent outbreaks of colonization and infection in 84 
NICUs in both Dutch and German teaching hospitals. 85 
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MATERIALS AND METHODS 87 
Strains: Clinical S. marcescens isolates were obtained from three different 88 
institutions in Groningen (The Netherlands; n=41), Cologne (Germany; n=19) and 89 
Freiburg (Germany; n=51), respectively.  90 
The 41 isolates from the University Medical Center Groningen were obtained 91 
between 2014 and 2017 from 38 patients of which 4 were adults in non-pediatric 92 
wards (2 in cardiology, 1 in orthopedics and 1 in obstetrics), 2 were from children > 93 
12 year in the pediatric ICU (PICU), 1 from a child > 18 months and the others from 94 
children < 6 months either on the pediatric special care unit (n=1), the pediatric 95 
general surgery ward (n=2), the PICU (n=2), or the NICU (n=26). From three patients 96 
two isolates were sequenced. In one case, in addition to a positive culture from a 97 
rectal swab of the patient also an isolate was cultured from the intravenous line, but 98 
this isolate appeared to be a S. liquefaciens, originally misidentified as S. 99 
marcescens by conventional diagnostic methods. All other isolates were cultured 100 
from patients in the NICU using growth-based microbiology technology (see Figure 1 101 
for additional details on strain origin). The 19 isolates from Cologne were isolated 102 
between 2014 and 2017 and all originate from NICUs, PICUs and general wards. 103 
The age of the patients varied between 4 days and 11 months. The collection of 104 
isolates consisted of 5 epidemiologically related transmission clusters and 2 105 
singleton isolates (see Figure 2 for additional details). The 51 isolates from Freiburg 106 
mostly originated from the local NICU (n=39) with patient age varying between 0 and 107 
12 weeks. Seven environmental isolates were included for comparative reasons and 108 
to gauge the relevance of environmental spread. For several patients (A to H, n=8) 109 
multiple isolates were included in order to define basic levels of intra-patient 110 
variability of S. marcescens (see Figure 3 for additional details). 111 
Isolates were either directly processed or stored at -80oC in glycerol-containing 112 
media until culture for DNA isolation and genome sequencing. In addition to the 113 
WGS data, clinical and epidemiological data were included. Metadata included, but 114 
were not limited to, isolation dates, outbreak associations, patients’ gender and age, 115 
type (and outcome) of infections, specimen types submitted for microbiological 116 
analyses, location of the ward and whether local typing data obtained previously 117 
were available. 118 
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DNA isolation: DNA was extracted using the Ultraclean Microbial DNA isolation kit 119 
(MoBio Laboratories, Carlsbad, CA, USA) or the MagAttract HMW DNA Isolation kit, 120 
in both cases following the manufacturer's instructions (Qiagen, Hilden, Germany) 121 
and quantified using a NanoDrop 2000c spectrophotometer (Thermo Fisher 122 
Scientific Inc, Waltham, MA, USA) and/or the Qubit dsDNA HS assay (Thermo 123 
Fisher Scientific GmbH, Schwerte, Germany). 124 
Genome sequencing: DNA libraries were prepared using the Nextera XT library 125 
preparation kit and the Nextera XT v2 index kit (Illumina, San Diego, CA, USA). The 126 
library was sequenced on a MiSeq, using the reagent kit v2 generating 250-bp 127 
paired-end reads. Supplementary Tables 1A to 1C disclose the quality parameters 128 
for the sequences determined. All WGS included met with the required quality 129 
criteria and all primary sequences were deposited in the public domain (ENA project 130 
numbers PRJEB28358 and PRJEB28681). 131 
Development of the wgMLST scheme: A scheme for wgMLST of S. marcescens 132 
was developed using publicly available WGS data for this species (June 2017), and 133 
will be made commercially available through a plugin in BioNumerics™ (Applied 134 
Maths NV, St-Martens-Latem, Belgium). The scheme is intended to facilitate 135 
detection of subtype- or outbreak-specific markers. Using a selection of 299 136 
annotated, publicly available reference genomes which were assumed to capture the 137 
diversity within S. marcescens, a pan-genomic scheme with high discriminatory 138 
power was developed (see Supplementary Table 2 for a list of all WGS included). 139 
Starting from the reference genomes, our scheme creation procedure uses a 140 
sampling-based multi-reciprocal BLAST procedure to determine those sets of alleles 141 
that make up the stable loci in the pan-genome. A per-locus allele assessment 142 
procedure then determines the central prototype allele, and thus the definition of the 143 
locus. The wgMLST scheme for S. marcescens was tested, validated and approved 144 
by epidemiological and microbiological analyses using information on the strain 145 
collections from Groningen, Cologne and Freiburg.  146 
Bioinformatic analyses: De novo genome assembly for all WGS was performed 147 
using SPAdes 3.7.1. All de novo calculations were run on the cloud-based 148 
calculation engine that comes with BioNumerics™ 7.6.3. wgMLST analysis was also 149 
performed using the BioNumerics™ cloud-based calculation engine. Alleles were 150 
identified by both an assembly-free k-mer based approach using the raw reads and 151 
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an assembly-based BLAST approach. Identification was done against the S. 152 
marcescens wgMLST database in BioNumerics™. Categorical coefficients were 153 
used for defining similarity levels and Unweighted Pair Group Method with Arithmetic 154 
Mean (UPGMA) was used as clustering algorithm. Minimum spanning trees (MST) 155 
were constructed using the wgMLST allelic profiles as input data. The size of the 156 
nodes was chosen proportional to the number of isolates in the nodes (i.e. isolates 157 
with the same allelic profiles). Branch lengths reflect the number of allele differences 158 
between the isolates in the connected nodes.  159 
 160 
RESULTS 161 
A new system for wgMLST for S. marcescens: In total, 299 reference genome 162 
sequences were included while building the wgMLST scheme. These displayed a 163 
conformity between 85% and 97% after constructing the scheme and showed an 164 
average of 95% global coverage of the included loci. The scheme was validated in 165 
August 2017 on the basis of 373 sequence read archives (SRA), which included all 166 
Illumina data sets publicly available as of 28 August 2017. In this way, a total of 167 
9,377 loci were added to the scheme, including 1455 loci which were present in all 168 
references and 7922 accessory loci. The wgMLST scheme had high discriminatory 169 
power and allowed for the detection of markers specific for S. marcescens subtypes 170 
or outbreak strains, thus enabling powerful classification and outbreak definition (see 171 
Figure 4C). The two allele detection procedures (either assembly-based or 172 
assembly-free) performed fast and reliable allele calling for cluster detection. Figure 173 
4A indicates the diversity within the reference genome set, and provides an overview 174 
of the number of clusters as function of the similarity cutoff value, indicating the 175 
presence of both distant and highly related isolates in the reference set of 299 176 
strains. Figure 4B depicts the number of pairwise allelic differences and the 177 
frequency of their occurrence peaking at about 4000 allelic differences given the 178 
current wgMLST scheme complexity. Figure 4C shows a global perspective of the 179 
genomic diversity among the references used to build the wgMLST scheme, where 180 
all circles identify distinct wgMLST types (as also semi-quantified by the number of 181 
allelic differences quantified on the branches) and the colored blocks identify isolates 182 
of more closely related and sometimes indistinguishable genomic sequences. This 183 
confirms our assumption that the genome sequences obtained from the public 184 
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domain show significant levels of diversity allowing them to serve as reference of 185 
genomic variability. Overall, the quality parameters indicate that the scheme covers 186 
the diversity within the species and provides sufficient resolving power for 187 
distinguishing even closely related bacterial isolates. Finally, it seems that the 188 
population structure of S. marcescens is largely genetically diverse with many 189 
singletons present. However, there seem to be indications for the successful 190 
expansion of clones (colored circles, Figure 4C). 191 
Strain characteristics and outbreak features: It has to be stated that only one 192 
patient died as a consequence of S. marcescens colonization/infection. Also, 193 
presence was mostly due to colonization and real infection was only apparent in a 194 
limited number of cases (Groningen 9 of 38 patients (24%); Cologne 2/16 (13%); 195 
Freiburg 6/23 (26%) (one sample of unknown origin)). Overall, 22% patients had an 196 
infection.  197 
Groningen outbreak analyses: Forty-one clinical isolates were obtained 198 
from 38 patients in the University Medical Center Groningen (UMCG). The wgMLST 199 
analysis detected a small cluster of related isolates: five isolates obtained from three 200 
patients in May-June in 2015 (cluster 0003 in Figure 1). From one patient two 201 
isolates from the rectal swab appeared to be 100% wgMLST identical and from the 202 
other patient the isolate found in the blood was identical to the one found in the rectal 203 
swab. In addition, a larger cluster was found containing isolates, all from different 204 
patients, from a protracted outbreak in August-November 2014 (cluster 0005 in 205 
Figure 1). The single invasive isolate that was isolated during this episode was 206 
indistinguishable from the other isolates. In addition, four suspected cases of single 207 
transmission events involving two patients were confirmed as well (clusters 0001, 208 
0002, 0004, 0006 and 0007 in Figure 1). Hence, the clustering aligns very well with 209 
the prior epidemiological scenarios. The 0002 cluster contained two separate 210 
isolates from the same patient, showing the reproducibility of the method. All isolates 211 
contained the aminoglycoside resistance-associated gene aac(6’)-I-C and about half 212 
of them contained the tetracycline resistance determinant Tet (41). A single multi-213 
resistant isolate was cultured from the synovial fluid of an elderly female nursed at 214 
the orthopedics department. The origin of this strain is not clear. 215 
Cologne outbreak analyses: wgMLST analysis of the 19 isolates from the 216 
Cologne University hospital correctly defined the anticipated clustering and identified 217 
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two main outbreak clusters and three cases where inter-patient transfer was already 218 
suspected (Cologne-1 to Cologne-5). The two singleton isolates were separated 219 
from all of the other isolates. Figure 2 summarizes the overall data and sketches the 220 
outbreak scenarios also showing that all related isolates were 100% identical at the 221 
wgMLST level. One of the singleton isolates contained at least 8 different resistance 222 
genes. 223 
Freiburg outbreak analyses: The collection of isolates derived from the 224 
laboratory in the Freiburg University hospital contained 47 out of 51 isolates that 225 
were nearly indistinguishable by wgMLST (Figure 3, green boxes), indicating a local 226 
outbreak which occurred in October and November 2015 involving 19 patients and 7 227 
environmental isolates. Additionally, two isolates were identified (red boxes, Figure 3) 228 
that were not distinguished by wgMLST, reflecting a single, known transmission 229 
event of a different strain type outside the NICU. Most of the outbreak isolates were 230 
considered to represent colonization rather than infection or bacteremia (16/19 231 
patients). All  serial isolates obtained from individual patients were identical at the 232 
wgMLST level. Only in case of patients F and H small differences were documented 233 
but within the boundaries of the epidemiological cut-off value. Finally, the 234 
environmental isolates all fell within the same outbreak category. 235 
Minimum spanning trees: Figure 5 displays the minimum spanning trees for 236 
the three studies and there is good concordance with the UPGMA trees in Figures 1-237 
3. The number of allele differences ranged between 0 and 4 for the epidemiologically 238 
defined strain clusters with two exceptions. There is only a single strain in the 239 
Freiburg cluster that differs by 18 alleles from its counterparts. This suggests that a 240 
cut-off value of <20 alleles would represent a conservative but useful estimate for 241 
transmission-related isolates, also given the significantly higher genetic distance 242 
between the non-related S. marcescens isolates. Figure 6 once more displays the 243 
robustness of the wgMLST scheme since while including all WGS entries in the 244 
database, still the strain clusters identified above remain unchanged.  245 
 246 
DISCUSSION 247 
S. marcescens is a nosocomial pathogen of clinical importance and both species 248 
identification and antimicrobial susceptibility testing are well covered in routine 249 
diagnostic clinical microbiology laboratories. However, epidemiological typing of S. 250 
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marcescens is less developed, and for this reason we developed a wgMLST scheme. 251 
The system allowed for the adequate recognition of clonally related organisms and it 252 
allowed for the detection of outbreak events. At the level of wgMLST the number of 253 
changes between the most closely related isolates were less than twenty alleles 254 
(given the time frame during which our outbreak related strains were captured), 255 
although a significant fraction of the closely related genomes only differed by 0-4 256 
alleles. This latter level of resolution does not allow for detailed epidemiological 257 
tracing of spread from one patient to the other given the apparently low number of 258 
changes associated with such transfers. We performed a limited number of wgSNP 259 
analyses and, surprisingly, for the ten related isolates from Groningen, this did not 260 
increase the resolution. The number of SNPs encountered between the ten isolates 261 
ranged from zero to five, in the same range as the wgMLST variation and insufficient 262 
to decipher transmission of strains between patients (data not shown). Of note, a 263 
recent cgMLST study for Brucella melitensis revealed similar findings: 264 
epidemiological cut off values for non-variance were defined as <6 loci for wgMLST 265 
and <7 loci for wgSNP analyses, similar to what we document here for S. 266 
marcescens (19). 267 
Next generation sequencing (NGS) is becoming very popular in clinical microbiology 268 
(20,21), but wgMLST for S. marcescens has not yet been described. WGS has been 269 
used to study S. marcescens virulence after wound infections and infection of snake 270 
bites (22). As well, WGS has been used to study the national dissemination of drug 271 
resistance elements and plasmids in S. marcescens throughout Germany, although 272 
only a limited number of isolates were subjected to NGS (16). The same authors 273 
also demonstrated that S. marcescens genomes can be used to generate genomic 274 
catalogues of antibiotic resistance genes. Relevant to our current clinical study is the 275 
work done by Iguchi et al (23). These authors defined the WGS for two selected S. 276 
marcescens strains. Their analysis revealed a degree of genetic heterogeneity that 277 
our current study exploited. Iguchi et al (23) already tried to define core and variable 278 
genes and used ways for defining genetic distance between S. marcescens isolates. 279 
Most recently, Martineau and colleagues (24) used WGS to elucidate transmission 280 
patterns in a NICU in Montreal, Canada. WGS for ten clinical isolates were 281 
instrumental in resolving S. marcescens routes of spread in this setting. We were 282 
able to confirm their data using our wgMLST scheme (results not shown). In the 283 
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examples brought forward by Martineau et al, a single outbreak was analyzed, where 284 
we have now taken the method to a higher level including the development of a 285 
dedicated wgMLST WGS database and an informatics tool for the semi-automated 286 
analysis of potential outbreak scenarios. With turnaround calculation times of less 287 
than 30 minutes per sample and simultaneous processing of up to 24 samples, high-288 
powered wgMLST performance is guaranteed. Using BioNumerics™ and a cloud-289 
based calculation engine, it provides a high-throughput environment that enables a 290 
fast and simple outbreak analysis of WGS data for S. marcescens. The calculation 291 
engine’s quality-controlled de novo assembly possibilities allow for rapid, push-292 
button assembly of WGS data without the need of local computing power. In short, 293 
even high resolution typing needs optimal epidemiological data and cannot stand on 294 
its own. Although we here focus on patients in NICUs it should be emphasized that 295 
genomic typing of S. marcescens will have wider implications as these bacteria infect 296 
other risk groups as well (25,26). We acknowledge the fact that we are not disclosing 297 
the precise methodology used for wgMLST scheme development since this module 298 
will become available only in combination with BioNumerics™. 299 
In conclusion, all laboratory-run typing methods, wgMLST included, are valuable in 300 
the context of hospital-wide screening for pathogens but also for analyses of random 301 
clinical isolates (27,28). wgMLST for S. marcescens has here been demonstrated to 302 
be a promising epidemiological typing support tool. In combination with tools for 303 
deciphering a genomic antibiogram and the presence of virulence genes, WGS by 304 
NGS may help trace and follow outbreaks, understand the acquisition and spread of 305 
resistance factors and explain the disease invoking potential for this not-to-be-306 
underestimated human pathogen. 307 
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LEGENDS TO THE FIGURES  440 
 441 
Figure 1 UPGMA tree of the pan-genomic allelic profiles (n=25) derived for S. 442 
marcescens isolates from the University Medical Center Groningen, The Netherlands. 443 
Outbreaks and transfer events identified prior to our study (0001-0007) are 444 
 o
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highlighted by color, with relevant microbiological, host-associated and 445 
environmental metadata displayed to the right. The UPGMA tree which was built 446 
using a similarity coefficient based on categorical values expressed as a percentage. 447 
Strain UMCG-029, located at the bottom of the tree, represents S. liquefaciens, a 448 
species only sharing about 2900 loci with the S. marcescens wgMLST scheme, as 449 
opposed to 4300 loci that are typically detected in S. marcescens. 450 
 451 
Figure 2 UPGMA tree of the pan-genomic allelic profiles (n=7) derived for S. 452 
marcescens isolates from the Institute for Medical Microbiology, Immunology and 453 
Hygiene at the  University of Cologne, Germany. Outbreaks and transfer events 454 
(Cologne-1 to Cologne-5) identified prior to our study are highlighted by color, with 455 
relevant microbiological, host-associated and environmental metadata displayed to 456 
the right. The UPGMA tree which was built using a similarity coefficient based on 457 
categorical values expressed as a percentage. Isolates originating from inanimate 458 
surfaces are highlighted in blue. 459 
 460 
Figure 3 UPGMA tree of the pan-genomic allelic profiles (n=4) derived for S. 461 
marcescens isolates from the University Hospital of Freiburg, Germany. A single 462 
major outbreak event generated all strains except four (red and non-boxed). 463 
Relevant microbiological, host-associated and environmental metadata are displayed 464 
to the right. The UPGMA tree was built using a similarity coefficient based on 465 
categorical values expressed as a percentage. Note that in this case multiple 466 
isolates were included for 8 different individuals. Isolates originating from inanimate 467 
surfaces are highlighted in blue. 468 
 469 
Figure 4 Review of quality parameters for the S. marcescens specific whole genome 470 
sequences used to construct the wgMLST reference database. 471 
Figure 4A Correlation between number of clusters and similarity cutoff values 472 
for the founding S. marcescens wgMLST database. The cluster index was 473 
based on the average number of alleles being different between closely 474 
related strain pairs. The analysis was performed using all WGS listed in 475 
Supplementary Table 2. 476 
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Figure 4B Correlation between the numbers of pairwise allelic differences and 477 
their frequency of occurrence. 478 
Figure 4C Minimum spanning tree based on the pan-genomic allelic profiles 479 
of 299 S. marcescens isolates, representing the reference set used to create 480 
the wgMLST database. Colors highlight closely related isolates, numbers of 481 
allelic differences are indicated on the lines connecting the various types. 482 
 483 
Figure 5 Minimum spanning trees for the S. marcescens isolates from Groningen, 484 
Cologne and Freiburg built from the pan-genomic allelic profiles. Colors of the circles 485 
identify the epidemiological clusters and cases of transmission. Figures on the axes 486 
identify the numbers of allelic differences between the connected isolates. Circle size 487 
is associate with the number of isolates per type. The figure implies that there are no 488 
clusters extending across hospitals. Color codes are specific for the three different 489 
panels and should not be compared between panels.  490 
 491 
Figure 6 Overall genomic population structure of S. marcescens based on a 492 
combined analysis of our epidemiologically related isolates and the reference 493 
genomes that were used to construct the wgMLST scheme. Note the extended 494 
number of singletons and the occurrence of epidemic clones seemingly originating 495 
from several of such singletons. Green bullets represent isolates from Groningen, 496 
red ones the isolates from Cologne and blue ones identify the isolates from Freiburg. 497 
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